Login
Home
Charts
Search
Watchlist
Products

Astral Ltd

ASTRAL·NSE
1,381.60-1.38%Tue, 22 Sept '26

Astral Ltd

ASTRAL
NSE
1,381.60
-1.38%
|Tue, 22 Sept '26
SOICxStockScans Reports
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
37,117Cr
Close
Close Price
1,381.60
Industry
Industry
Building Materials - Plastic Pipes
PE
Price To Earnings
64.47
PS
Price To Sales
5.47
Revenue
Revenue
6,785Cr
Rev Gr TTM
Revenue Growth TTM
16.79%
PAT Gr TTM
PAT Growth TTM
20.29%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,3631,3701,6251,3841,3701,3971,6811,3611,5771,5422,0891,578
Growth YoY
Revenue Growth YoY%
16.38.17.97.80.52.03.5-1.615.110.324.215.9
Expenses
ExpensesCr
1,1431,1651,3341,1691,1601,1781,3801,1761,3211,3041,7061,347
Operating Profit
Operating ProfitCr
220205292214210220302185257237383231
OPM
OPM%
16.115.017.915.515.315.718.013.616.315.418.314.7
Other Income
Other IncomeCr
13610129129911-71113
Interest Expense
Interest ExpenseCr
8888101410121613246
Depreciation
DepreciationCr
495053566063657272737475
PBT
PBTCr
177154241163149154236110180144297163
Tax
TaxCr
454160444042583145378443
PAT
PATCr
13211318112010911317879135108213120
Growth YoY
PAT Growth YoY%
75.619.0-12.10.2-17.5-0.6-1.8-33.724.0-4.319.651.8
NPM
NPM%
9.78.311.28.67.98.110.65.88.67.010.27.6
EPS
EPS
4.94.26.84.54.14.36.73.05.04.07.94.5
QuarterSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue
RevenueCr
1,3631,3701,6251,3841,3701,3971,6811,3611,5771,5422,0891,578
Growth YoY
Revenue Growth YoY%
16.38.17.97.80.52.03.5-1.615.110.324.215.9
Expenses
ExpensesCr
1,1431,1651,3341,1691,1601,1781,3801,1761,3211,3041,7061,347
Operating Profit
Operating ProfitCr
220205292214210220302185257237383231
OPM
OPM%
16.115.017.915.515.315.718.013.616.315.418.314.7
Other Income
Other IncomeCr
13610129129911-71113
Interest Expense
Interest ExpenseCr
8888101410121613246
Depreciation
DepreciationCr
495053566063657272737475
PBT
PBTCr
177154241163149154236110180144297163
Tax
TaxCr
454160444042583145378443
PAT
PATCr
13211318112010911317879135108213120
Growth YoY
PAT Growth YoY%
75.619.0-12.10.2-17.5-0.6-1.8-33.724.0-4.319.651.8
NPM
NPM%
9.78.311.28.67.98.110.65.88.67.010.27.6
EPS
EPS
4.94.26.84.54.14.36.73.05.04.07.94.5

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,6781,8952,0732,5072,5783,1764,3945,1595,6415,8326,5696,785
Growth
Revenue Growth%
17.312.99.421.02.823.238.317.49.43.412.616.8
Expenses
ExpensesCr
1,4701,6311,7562,1222,1352,5323,6394,3494,7234,8875,5075,677
Operating Profit
Operating ProfitCr
2082643173854436457558109189461,0621,108
OPM
OPM%
12.413.915.315.317.220.317.215.716.316.216.216.3
Other Income
Other IncomeCr
-4610121118332342412528
Interest Expense
Interest ExpenseCr
301822323913134029416458
Depreciation
DepreciationCr
42505781108117127178198243292295
PBT
PBTCr
132201248283306533649615734703731784
Tax
TaxCr
3056728657125158156188184196208
PAT
PATCr
102145176197250408490460546519535576
Growth
PAT Growth%
30.441.821.512.326.563.520.1-6.318.7-4.93.020.3
NPM
NPM%
6.17.68.57.99.712.811.28.99.78.98.18.5
EPS
EPS
3.85.46.65.89.315.118.017.020.319.520.021.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
1,6781,8952,0732,5072,5783,1764,3945,1595,6415,8326,5696,785
Growth
Revenue Growth%
17.312.99.421.02.823.238.317.49.43.412.616.8
Expenses
ExpensesCr
1,4701,6311,7562,1222,1352,5323,6394,3494,7234,8875,5075,677
Operating Profit
Operating ProfitCr
2082643173854436457558109189461,0621,108
OPM
OPM%
12.413.915.315.317.220.317.215.716.316.216.216.3
Other Income
Other IncomeCr
-4610121118332342412528
Interest Expense
Interest ExpenseCr
301822323913134029416458
Depreciation
DepreciationCr
42505781108117127178198243292295
PBT
PBTCr
132201248283306533649615734703731784
Tax
TaxCr
3056728657125158156188184196208
PAT
PATCr
102145176197250408490460546519535576
Growth
PAT Growth%
30.441.821.512.326.563.520.1-6.318.7-4.93.020.3
NPM
NPM%
6.17.68.57.99.712.811.28.99.78.98.18.5
EPS
EPS
3.85.46.65.89.315.118.017.020.319.520.021.4

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212121215202027272727
Reserves
ReservesCr
6968351,0061,1931,4881,8762,3172,6843,1613,5904,031
Current Liabilities
Current LiabilitiesCr
4274534915876156889411,3341,1211,1431,498
Non Current Liabilities
Non Current LiabilitiesCr
155150152220155688281108220256
Total Liabilities
Total LiabilitiesCr
1,3041,4621,6752,0992,2892,6733,3874,3734,4985,0565,812
Current Assets
Current AssetsCr
6146767438719631,2691,7452,2491,9862,1492,639
Non Current Assets
Non Current AssetsCr
6907859321,2281,3261,4041,6422,1242,5122,9073,173
Total Assets
Total AssetsCr
1,3041,4621,6752,0992,2892,6733,3874,3734,4985,0565,812
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
Equity CapitalCr
1212121215202027272727
Reserves
ReservesCr
6968351,0061,1931,4881,8762,3172,6843,1613,5904,031
Current Liabilities
Current LiabilitiesCr
4274534915876156889411,3341,1211,1431,498
Non Current Liabilities
Non Current LiabilitiesCr
155150152220155688281108220256
Total Liabilities
Total LiabilitiesCr
1,3041,4621,6752,0992,2892,6733,3874,3734,4985,0565,812
Current Assets
Current AssetsCr
6146767438719631,2691,7452,2491,9862,1492,639
Non Current Assets
Non Current AssetsCr
6907859321,2281,3261,4041,6422,1242,5122,9073,173
Total Assets
Total AssetsCr
1,3041,4621,6752,0992,2892,6733,3874,3734,4985,0565,812

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2261142823424056645435578236301,117
Investing Cash Flow
Investing Cash FlowCr
-203-158-185-293-318-45472-480-541-513-507
Financing Cash Flow
Financing Cash FlowCr
1612-71-5-163-153-44-191-203-118-328
Net Cash Flow
Net Cash FlowCr
38-322544-7557571-11380-1282
Free Cash Flow
Free Cash FlowCr
22711528712219249319924727390661
CFO To PAT
CFO To PAT%
221.579.0160.4173.3162.4162.7110.8121.2150.9121.3208.9
CFO To EBITDA
CFO To EBITDA%
108.843.389.088.891.5103.071.968.889.766.6105.2
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
2261142823424056645435578236301,117
Investing Cash Flow
Investing Cash FlowCr
-203-158-185-293-318-45472-480-541-513-507
Financing Cash Flow
Financing Cash FlowCr
1612-71-5-163-153-44-191-203-118-328
Net Cash Flow
Net Cash FlowCr
38-322544-7557571-11380-1282
Free Cash Flow
Free Cash FlowCr
22711528712219249319924727390661
CFO To PAT
CFO To PAT%
221.579.0160.4173.3162.4162.7110.8121.2150.9121.3208.9
CFO To EBITDA
CFO To EBITDA%
108.843.389.088.891.5103.071.968.889.766.6105.2

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,0246,55710,72713,87713,92832,48140,65035,91253,46934,73242,90337,117
Price To Earnings
Price To Earnings
49.845.361.371.056.380.384.078.898.066.480.064.5
Price To Sales
Price To Sales
3.03.55.25.55.410.29.37.09.56.06.55.5
Price To Book
Price To Book
7.17.810.611.59.317.117.413.316.89.610.69.2
EV To EBITDA
EV To EBITDA
24.625.434.136.331.449.853.143.657.736.339.834.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.427.128.929.933.434.329.929.634.332.532.732.7
OPM
OPM%
12.413.915.315.317.220.317.215.716.316.216.216.3
NPM
NPM%
6.17.68.57.99.712.811.28.99.78.98.18.5
ROCE
ROCE%
19.321.723.622.521.127.627.223.423.119.318.418.4
ROE
ROE%
14.417.117.316.416.621.521.016.917.114.313.213.2
ROA
ROA%
7.89.910.59.410.915.314.510.512.110.39.29.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
5,0246,55710,72713,87713,92832,48140,65035,91253,46934,73242,90337,117
Price To Earnings
Price To Earnings
49.845.361.371.056.380.384.078.898.066.480.064.5
Price To Sales
Price To Sales
3.03.55.25.55.410.29.37.09.56.06.55.5
Price To Book
Price To Book
7.17.810.611.59.317.117.413.316.89.610.69.2
EV To EBITDA
EV To EBITDA
24.625.434.136.331.449.853.143.657.736.339.834.0
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.427.128.929.933.434.329.929.634.332.532.732.7
OPM
OPM%
12.413.915.315.317.220.317.215.716.316.216.216.3
NPM
NPM%
6.17.68.57.99.712.811.28.99.78.98.18.5
ROCE
ROCE%
19.321.723.622.521.127.627.223.423.119.318.418.4
ROE
ROE%
14.417.117.316.416.621.521.016.917.114.313.213.2
ROA
ROA%
7.89.910.59.410.915.314.510.512.110.39.29.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Astral Ltd is a company built on being first - it introduced India’s first CPVC (chlorinated polyvinyl chloride, a high-temperature plastic) pipes and first lead-free PVC pipes, and it has spent three decades turning that instinct into a portfolio of building-materials businesses that now reach from bathroom taps to industrial adhesives. It began in 1996 as a plumbing specialist and has since expanded by repeatedly spotting products that were mostly imported or had little organised competition in India, then making them itself - often by going further backwards than anyone else, right down to the raw material. That pattern - pioneer a category, then deepen control over its supply chain - is the thread that runs through everything the company does. # Business segments Three engines at different stages - a plumbing cash cow that is about to make its own raw material, a fast-growing adhesives-and-chemicals platform being carved out into a separate listed company, and a young paints business built on acquisitions - each extending the same distribution network. ## 1. Pipes, tanks and bathware: the plumbing core that makes its own inputs **Astral sells more than 56 different plumbing products through 13,000 towns, and it is building India’s first captive CPVC resin plant so it no longer has to import its most important raw material.** - **First to market, again and again** - the company introduced India’s first CPVC pipes and fittings, first lead-free uPVC pipes, and first CPVC fire-sprinkler fittings with ISI certification, which means it has decades of brand recognition with plumbers and builders before competitors arrive. - **Backward integration into the molecule** - a 40,000 metric-tonne CPVC resin plant is under construction at Santej, with trials expected by December 2026 and commercial output in early 2027; the plant is designed to double easily and, the company says, will cost roughly a fifth of what rivals have spent on similar capacity. - **A product for every pipe in the building** - the range spans CPVC for hot water, PP drainage systems (three tiers, from a dense cast-iron replacement to a retail-grade PVC alternative), PEX-aluminium composite pipes for concealed high-rise plumbing, OPVC pipes that substitute for ductile iron in municipal water supply, and a patented electrofusion drainage system that competes with imported gabit systems. - **Decentralised plants, centralised trust** - 6 manufacturing units spread across India put production close to demand, and every CPVC pipe carries two unique codes that a layman can verify to check authenticity, batch, plant and originating distributor - a system that took over two years to build. ## 2. Adhesives, sealants and construction chemicals: the second engine, soon to be a standalone company **What started as an adhesive acquisition 13 years ago is now a multi-chemistry business selling through more than 2 lakh retail touchpoints, with a demerger planned to list it separately.** - **Nine chemistries under one roof** - the division makes epoxy adhesives and putties (the original product), PVA white glue, rubber adhesives, anaerobic engineering adhesives, tapes, silicone sealants, instant adhesives and waterproofing compounds, giving it a presence across bonding, tiling, coating and plumbing-ancillary jobs. - **Built by buying and then scaling** - entry came through the 2014 acquisition of UK-based Seal It Services and Kanpur-based Resinova Chemie; since then, a large automated plant at Dahej (39,000 MT capacity) has been added, cutting raw-material costs through bulk buying and improving batch consistency. - **Rural reach through a dedicated channel** - a “New Bharat” vertical clubs retail, construction-chemical and wood-adhesive products into a single sales force targeting villages with populations of 2,000-10,000, where 69% of India’s population lives. - **From trade push to consumer pull** - the Bondtite brand appointed Ranbir Kapoor as its ambassador in 2025-26 and entered modern retail, while a network of more than 70,000 active professionals (plumbers, carpenters, contractors) drives specification at the job site. - **Market leadership where it matters** - the company says it is the number-two Indian player in adhesive sealants and holds the top position in solvent cements, the glues used to join plastic pipes. ## 3. Paints: the third leg, rebuilt from scratch **Astral bought a South Indian paint company, threw out its formulations, and launched a new decorative range under its own brand - using the same logic that paints and construction chemicals travel together.** - **Acquired, then reformulated** - a 51% stake in Gem Paints (Karnataka, 36,000 kilolitre capacity) was taken in 2022, but every formulation was redone from scratch against top Indian benchmarks before the “Astral Paints” brand launched in 2024. - **Dual-brand geography** - “Astral Coatings” sells in western and central India (successful launches in Gujarat and Rajasthan), while the legacy “Gem Paints” brand continues in the South, where it has over 3,000 dealers and strong recognition. - **Dealer-first, painter-first** - the company gives its own tinting machines to loyal dealers and launched a painter-and-contractor loyalty app on day one, betting that the influencer at the mixing bench is as important as the shopkeeper. - **Phase one is decorative; phase two goes industrial** - the current range covers interior and exterior emulsions, waterproofing paints, primers, putties and enamels; wood coatings and marine coatings are planned next. # Group structure and partners **A composite scheme announced in June 2026 aims to demerge the chemicals business into a separately listed entity and fold a recently acquired fittings maker into the parent - but the plan is under independent review following stakeholder feedback.** - **The demerger logic** - the Chemicals Business Undertaking (adhesives, sealants, construction chemicals, putties and allied products) would move from Astral Limited into Astral Chemie Limited, which already houses the paints business, creating a single listed chemicals platform with focused leadership and mirror shareholding. - **Fittings brought in-house** - Al-Aziz Plastics, acquired for ₹33 crore, makes electrofusion and compression fittings, irrigation sprinklers and solar accessories (4,690 MT capacity); under the scheme it would be amalgamated into Astral Limited to sit alongside the plumbing business. - **Raw-material control deepened** - an 80% stake in Nexelon Chem was acquired in November 2025 specifically to manufacture CPVC resin, the main feedstock for the pipes division. - **International adhesives outposts** - wholly owned Seal IT Services in the UK (recently returned to positive EBITDA after a turnaround) and its US subsidiary sell sealants, foams and waterproofing products, with a step-down Irish entity handling EU regulatory requirements. - **Specialty chemicals entry** - Astral Chemie acquired a 60% stake in Differentiated and Sustainable Solutions LLP in June 2026, gaining technology for polyamines, bismaleimides and benzoxazines used in electronics, aerospace and composites (5,200 MT capacity).

Documents — Astral Ltd

  • Q1 FY2027 Earnings Call Transcript (Jun 2026, PDF): https://www.stockscans.in/document/as-b565f65eaeb85ca3bf81cf85.pdf
  • Q4 FY2026 Earnings Call Transcript (Mar 2026, PDF): https://www.stockscans.in/document/b4lllx41j73mglg0rpva7t53.pdf
  • Q2 FY2026 Earnings Call Transcript (Sep 2025, PDF): https://www.stockscans.in/document/pubaijikmfoo4usr14ec58up.pdf
  • Q1 FY2026 Earnings Call Transcript (Jun 2025, PDF): https://www.stockscans.in/document/knlltpkl3uq4bnxihzemt6k7.pdf
  • Q4 FY2025 Earnings Call Transcript (Mar 2025, PDF): https://www.stockscans.in/document/d63waurcz67ls6lwsnvq2p30.pdf
  • Q3 FY2025 Earnings Call Transcript (Dec 2024, PDF): https://www.stockscans.in/document/mrpkesq5yp82ezyqksgwi2jk.pdf
  • Q2 FY2025 Earnings Call Transcript (Sep 2024, PDF): https://www.stockscans.in/document/f8vpswgw8oi953mya2fmgd2z.pdf
  • Q1 FY2025 Earnings Call Transcript (Jun 2024, PDF): https://www.stockscans.in/document/9vynm16nu4bzxzyrb5rd9vjm.pdf
  • Q1 FY2027 Quarterly Result (Jun 2026, PDF): https://www.stockscans.in/document/hwcmz9hok5n26ew0g39zjv46.pdf
  • Q4 FY2026 Quarterly Result (Mar 2026, PDF): https://www.stockscans.in/document/7lqkut76zlz8xv8gvcfi3288.pdf
  • Q3 FY2026 Quarterly Result (Dec 2025, PDF): https://www.stockscans.in/document/spls7hc3xwifttozs7bx2t4t.pdf
  • Q2 FY2026 Quarterly Result (Sep 2025, PDF): https://www.stockscans.in/document/y53kumihtilme2gceb70bqgj.pdf
  • Q1 FY2026 Quarterly Result (Jun 2025, PDF): https://www.stockscans.in/document/mlpdzyxddyv7uv46xpwjwjst.pdf
  • Q4 FY2025 Quarterly Result (Mar 2025, PDF): https://www.stockscans.in/document/jkqu8c8irn49f8drurirrbzb.pdf
  • Q3 FY2025 Quarterly Result (Dec 2024, PDF): https://www.stockscans.in/document/kvr9knzcbe12r7r2u2b9j8w2.pdf
  • Q2 FY2025 Quarterly Result (Sep 2024, PDF): https://www.stockscans.in/document/abdmu6uq7j2vrdtbjfi5gojq.pdf
  • Q4 FY2026 Investor Presentation (Mar 2026, PDF): https://www.stockscans.in/document/e9q9pbhrb3evv3q7gsxik06y.pdf
  • Q4 FY2025 Investor Presentation (Mar 2025, PDF): https://www.stockscans.in/document/poi5lmtqe7ewmzviw9vlwh22.pdf
  • Q4 FY2024 Investor Presentation (Mar 2024, PDF): https://www.stockscans.in/document/li68xj7q0uyjhfd1wdlci223.pdf
  • FY2026 Annual Report (PDF): https://www.stockscans.in/document/ar64xbqv45295e84s1080pas.pdf
  • FY2025 Annual Report (PDF): https://www.stockscans.in/document/qktpd5c522qg9cgns24otgem.pdf
  • FY2024 Annual Report (PDF): https://www.stockscans.in/document/eidputfotny0hfx24me1dg91.pdf
  • FY2023 Annual Report (PDF): https://www.stockscans.in/document/wmxk9aa1zt8n7h84ddvy2twb.pdf
  • FY2022 Annual Report (PDF): https://www.stockscans.in/document/18p2dd07z8k71g4r8vmuty0t.pdf
  • FY2021 Annual Report (PDF): https://www.stockscans.in/document/053jycq11i24kxggihzpndbl.pdf
  • FY2020 Annual Report (PDF): https://www.stockscans.in/document/k44uhceip7hve4cqgdkok8ya.pdf

Concall Transcript Summaries — Astral Ltd

  • Q1 FY2027 Concall Transcript Summary (Jun 2026): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202606/as-b565f65eaeb85ca3bf81cf85.pdf
  • Q4 FY2026 Concall Transcript Summary (Mar 2026): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202603/b4lllx41j73mglg0rpva7t53.pdf
  • Q2 FY2026 Concall Transcript Summary (Sep 2025): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202509/pubaijikmfoo4usr14ec58up.pdf
  • Q1 FY2026 Concall Transcript Summary (Jun 2025): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202506/knlltpkl3uq4bnxihzemt6k7.pdf
  • Q4 FY2025 Concall Transcript Summary (Mar 2025): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202503/d63waurcz67ls6lwsnvq2p30.pdf
  • Q3 FY2025 Concall Transcript Summary (Dec 2024): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202412/mrpkesq5yp82ezyqksgwi2jk.pdf
  • Q2 FY2025 Concall Transcript Summary (Sep 2024): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202409/f8vpswgw8oi953mya2fmgd2z.pdf
  • Q1 FY2025 Concall Transcript Summary (Jun 2024): https://www.stockscans.in/company/NSE%3AASTRAL/transcript-notes/202406/9vynm16nu4bzxzyrb5rd9vjm.pdf